Growth, bone health & ambulatory status of boys with DMD treated with daily vs intermittent oral glucocorticoid regimen
Bone Jul 28, 2018
Crabtree NJ, et al. - In this pragmatic longitudinal study authors compared growth, body mass, bone mineral density (BMD), vertebral fractures (VF) and ambulatory status in boys with Duchenne muscular dystrophy (DMD) between daily or intermittent oral glucocorticoids (GC) regimens. At the cost of more vertebral fractures, greater adiposity and markedly diminished growth, more boys on daily GCs were seen to remain ambulant. On the contrary, fewer vertebral fractures were seen in boys on intermittent GCs, however, more boys lost independent ambulation.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries